NCT01921933View on ClinicalTrials.gov

The Optiflow Patency and Maturation Study

NACompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

October 31, 2015

Study Completion Date

January 31, 2016

Conditions
End-stage Kidney DiseaseEnd-stage Renal Disease
Interventions
DEVICE

Optiflow

The Optiflow device will be implanted in the upper extremity of Adult end-stage renal disease (ESRD) patients requiring creation of an upper extremity autogenous arteriovenous fistula for dialysis access.

Trial Locations (1)

45267-0585

University of Cincinnati - Division of Nephrology, Cincinnati

All Listed Sponsors
lead

Bioconnect Systems, Inc

INDUSTRY

NCT01921933 - The Optiflow Patency and Maturation Study | Biotech Hunter | Biotech Hunter